• Nie Znaleziono Wyników

Left ventricular noncompaction associated with genetic disturbance of folic acid metabolism

N/A
N/A
Protected

Academic year: 2022

Share "Left ventricular noncompaction associated with genetic disturbance of folic acid metabolism"

Copied!
2
0
0

Pełen tekst

(1)

KARDIOLOGIA POLSKA 2019; 77 (12) 1196

T (22.0 ng/l) subacute myocarditis was suspect- ed (FIGURE 1). Myocardial biopsy was not performed for technical reasons.

Patient was referred for genetic testing. Two mutations were found: methylenetetrahydrofo- late reductase (MTHFR) 1298 homozygote CC and MTHFR 677 heterozygote CT. Patient’s rela- tives did not undergo genetic testing. No hered- itary cardiovascular diseases in close relatives were documented.

The patient received recommendations to de- lay surgical procedure and start medical treat- ment with amiodarone. During follow-up, the patient had no complaints, no clinical signs of heart failure, and no thromboembolic events.

Left ventricular noncompaction is a cardio- myopathy caused by impaired evolution of pre- -natal myocardial compaction process. During embryogenesis, the intertrabecular recesses in- teract with the left ventricular endocardium, which leads to the formation of myocardial capil- laries.1 Left ventricular noncompaction can pres- ent as isolated abnormality or in combination with other hereditary structural defects such as Ebstein’s anomaly, bicuspid aortic valve, coro- nary arteries abnormalities, and septal defects.2

MTHFR gene codes MTHFR protein that is re- sponsible for intracellular homocysteine trans- formation to methionine. This enzyme requires pyridoxine, cyanocobalamin, and folic acid to perform its biological role. Detected gene mu- tations are known to be associated with struc- tural conformation changes of MTHFR protein binding sites responsible for binding to folic acid.

Alterations of the folic acid intracellular metab- olism during embryogenesis results in neural tube malformations.3,4 One of them is left ven- tricular noncompaction.

A 32-year old woman underwent a preoperative clinical examination before a planned breast surgery. Frequent polymorphic premature ven- tricular beats were observed on electrocardi- ography. She had never had any symptoms in the past, and no history of cardiovascular or rheumatic diseases.

The patient was examined by a cardiologist.

24-hour ambulatory electrocardiography mon- itoring showed sinus rhythm and 8500 evenly distributed polymorphic premature ventricu- lar beats, including 432 coupled extrasystoles.

Cardiac echocardiography showed normal car- diac chambers and nonaffected valvular struc- tures, high trabecularity of the left ventricle, and reduced ejection fraction (36%). Left ventricu- lar noncompaction was considered.

Cardiac magnetic resonance imaging with contrast enhancement was performed and con- firmed left ventricular noncompaction with re- duced systolic function.

Left ventricular end -diastolic volume was 200 ml, end -systolic volume, 131 ml, end -diastolic volume index, 122 ml/m2, end -systolic volume index, 80 ml/m2, stroke volume, 68 ml, cardiac output, 3.78 l/min, left ventricular ejection frac- tion, 34%. Diffusely reduced myocardial contrac- tility was detected, but it was more pronounced in lateral-inferior-septal region. Interventricu- lar septum was 11.8 mm, inferior wall, 13.7 mm.

High trabecularity of subendocardial region was found. End -diastolic ratio of layers was 2.3 in segments 7, 12, and 15 to 17. Subacute myocarditis was suspected based on edema in the interventric- ular septum with signs of inflammation located in the lateral -inferior region of the left ventricle associated with mild elevated levels of C -reactive protein (2.68 mg/l) and high -sensitivity troponin

Correspondence to:

Oleksandr Katerenchuk, PhD,  Department of Family Medicine  and Therapy, Ukrainian Medical  Stomatological Academy,  Shevchenka 23, Poltava, 36 004,  Ukraine, phone: +38 0532 60 20 51,  e mail: fmedicine@mail.ru Received: September 8, 2019.

Revision accepted:

October 14, 2019.

Published online:

October 15, 2019.

Kardiol Pol. 2019; 77 (12): 1196-1197 doi:10.33963/KP.15024 Copyright by the Author(s), 2019

C L I N I C A L V I G N E T T E

Left ventricular non compaction associated

with genetic disturbance of folic acid metabolism

Igor V. Ivanytskyi1, Oleksandr I. Katerenchuk1, Konstantin A. Nekrasov2, Tetyana A. Ivanytska3 1  Department of Family Medicine and Therapy, Ukrainian Medical Stomatological Academy, Poltava, Ukraine

2  Department of Molecular Oncogenetic Studies, Institute of Molecular Biology and Genetics, Kyiv, Ukraine 3  Department of Internal Medicine and General Practice, Ukrainian Medical Stomatological Academy, Poltava, Ukraine

(2)

C L I N I C A L V I G N E T T E Left ventricular noncompaction and folic acid metabolism abnormality 1197 Also, we need to take into account the possi-

ble role of comorbid subacute myocarditis on left ventricular noncompaction as the additional fac- tor for myocardial heterogeneity. Interesting- ly, the association of myocarditis with left ven- tricular noncompaction has been previously described.5

Of note, sporadic mutation of genes re- sponsible for folic acid metabolism can lead to formation of left ventricular noncompac- tion. This cardiomyopathy may be asymptom- atic for a prolonged period (which can last for decades). Comorbid subacute myocarditis can probably increase the risk of clinically signifi- cant arrhythmias.

ARTICLE INFORMATION

CONFLICT OF INTEREST None declared.

OPEN ACCESS This is an Open Access article distributed under the terms  of  the  Creative  Commons  Attribution -NonCommercial -NoDerivatives  4.0  In- ternational License (CC BY -NC -ND 4.0), allowing third parties to download ar- ticles and share them with others, provided the original work is properly cited,  not changed in any way, distributed under the same license, and used for non- commercial purposes only. For commercial use, please contact the journal office  at kardiologiapolska@ptkardio.pl.

HOW TO CITE Ivanytskyi IV, Katerenchuk OI, Nekrasov KA, Ivanytska TA. Left  ventricular non compaction associated with genetic disturbance of folic acid me- tabolism. Kardiol Pol. 2019; 77: 1196-1197. doi:10.33963/KP.15024

REFERENCES

1  Arbustini E, Favalli V, Narula N, et al. Left ventricular noncompaction a distinct  genetic cardiomyopathy? JACC. 2016; 68: 949-966.

2  Laaroussi L, Ben Halima A, Boukhris M, et al. Left ventricular non -compaction  associated with hypertrophic cardiomyopathy in the same patient. Kardiol Pol. 

2017; 75: 397.

3  Lupi -Herrera E, Soto -López ME, Lugo -Dimas AJ et al. Polymorphisms C677T  and A1298C of MTHFR Gene: Homocysteine Levels and Prothrombotic Biomarkers  in Coronary and Pulmonary Thromboembolic Disease. Clin Appl Thromb Hemost. 

2019; 25: 1076029618780344 [Epub ahead of print].

4  Moll S, Varga EA. Homocysteine and MTHFR Mutations. Circulation. 2015; 

132: 6-9.

5  Patil KG, Salagre SB, Itolikar SM. Left ventricular non -compaction with viral  myocarditis: a rare presentation of a rarer disease. J Assoc Physicians India. 2014; 

62: 261-263.

FIGURE 1 Cardiac magnetic resonance imaging (A, B) and echocardiography (C) showing left ventricular noncompaction. The arrows show the pathological hypertrabeculation of the left ventricle with 2 myocardial layers—normal and noncompacted

A B C

Cytaty

Powiązane dokumenty

Echocardiography demonstrated enlarged left ventricle (left ventricular end-diastolic volume [LVEDV] = 258 ml), with advanced mechanical asynchrony and severely impaired

titative variables (age, left ventricular ejection fraction, QRS before CRT system implantation, QRS after CRT system implantation, distance between the left and right

(left ventricular end-diastolic diameter [LVEDD], left ventricu- lar end-diastolic volume [LVEDV], left ventricular ejection fraction [LVEF], left ventricular end-systolic

The aim of our study was to investigate the use of L without a load- ing dose in a cohort of end-stage CHF patients ad- mitted to our institution for acute decompensation HF compared

The following subjects were also excluded from this study: patients with diabetes mellitus, hypertension, severe morbid obesity [body mass index (BMI) > 35], stage > three

An increase in mean left atrial or LV end-diastolic pressure will result in a reduction of RUPV systol- ic velocity and therefore mean RUPV systolic ve- locity in patients with

Echocardiographic parameters of LV systolic function including LVEF, LV end-diastolic volume (LVEDV), and LV end-systolic volume (LVESV) were compared between the study

During SCG the following parameters were analysed: pre-ejection period (PEP) in ms, left ventricular ejection time (LVET) in ms, PEP/LVET, myocardial performance index (MPI)